vVardis Secures $175 Million Ahead of Planned NYSE Listing
Swiss oral health company vVardis has raised $175 million in pre-IPO funding as it prepares to list on the New York Stock Exchange.
Swiss oral care company vVardis has raised $175 million in a funding round ahead of its anticipated initial public offering on the New York Stock Exchange, according to a pre-market advisory issued directly from the NYSE trading floor on Nov. 13, 2026.
The capital raise signals growing investor appetite for the company ahead of its public debut. The NYSE issues daily pre-market updates from its trading floor, and the vVardis funding announcement was highlighted as a notable development in that session's briefing.
Read more Leverage Shares Launches 2x Long Anthropic ETF as ANT Debuts on Nasdaq →
The timing of the raise positions vVardis to enter public markets with a substantial capital base, a strategy commonly used by companies seeking to demonstrate financial credibility and institutional backing before an IPO roadshow.
Details on the specific use of proceeds, the valuation implied by the raise, or the expected IPO pricing range were not disclosed in the NYSE advisory. The listing timeline on the NYSE also remains subject to regulatory and market conditions.
Continue reading at Economic News, Trends, Analysis.